argenx (NasdaqGS:ARGX) FY Conference Transcript

argenx (NasdaqGS:ARGX) FY Conference January 12, 2026 11:15 AM ET Company ParticipantsTim Van Hauwermeiren - Co-Founder and CEONone - Video NarratorKaren Massey - COOConference Call ParticipantsNone - AnalystRichard Vosser - European Pharma AnalystRichard VosserWelcome to the first day of the 44th JPMorgan Healthcare Conference. I'm Richard Vosser, European Pharma Analyst at JPMorgan. It's my great pleasure to introduce our argenx's CEO, Tim Van Hauwermeiren. Just a few housekeeping rules. We will take ques ...